Cochlear Limited (ASX:COH)
Australia · Delayed Price · Currency is AUD 124.86
-1.13 (-0.90%)
Aug 7, 2026, 4:10 PM AEST
Cochlear Market Cap
Cochlear has a market cap or net worth of 8.17 billion as of August 7, 2026. Its market cap has decreased by -60.17% in one year.
Market Cap
8.17B
Enterprise Value
8.22B
Revenue
2.34B
Ranking
n/a
PE Ratio
23.70
Stock Price
124.86
ChartMarket Cap Chart
Since December 12, 1995, Cochlear's market cap has increased from 44.18M to 8.17B, an increase of 18,383.15%. That is a compound annual growth rate of 18.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 8.17B | -52.10% |
| Dec 31, 2025 | 17.05B | -10.12% |
| Dec 31, 2024 | 18.97B | -3.04% |
| Dec 29, 2023 | 19.56B | 45.68% |
| Dec 30, 2022 | 13.43B | -5.54% |
| Dec 31, 2021 | 14.22B | 14.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 4DMedical | 2.83B |
| Imricor Medical Systems | 682.24M |
| PolyNovo | 601.03M |
| EBR Systems | 218.43M |
| Aroa Biosurgery | 193.71M |
| EMVision Medical Devices | 146.87M |
| Saluda Medical | 146.17M |
| Lumos Diagnostics Holdings | 122.77M |